Auteurs
Merge
Accueil
Racine
Merge
Exploration
Accueil
Racine
Accueil
Racine

Serveur d'exploration Tocilizumab - Merge (Accueil)

Index « Auteurs » - entrée « Akihiro Sudo »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Akihiro Sakakibara < Akihiro Sudo < Akihiro Tanaka  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 8.
Ident.Authors (with country if any)Title
000389 (2020) Koichi Nakamura ; Tomoki Nakamura ; Takahiro Iino ; Tomohito Hagi ; Kouji Kita ; Kunihiro Asanuma ; Akihiro SudoExpression of Interleukin-6 and the Interleukin-6 Receptor Predicts the Clinical Outcomes of Patients with Soft Tissue Sarcomas
000D14 (2019) Hiroki Wakabayashi ; Hitoshi Kino ; Makoto Kondo ; Keiichi Yamanaka ; Masahiro Hasegawa ; Akihiro SudoEfficacy of subcutaneous tocilizumab in patients with rheumatoid arthritis and systemic sclerosis overlap syndrome: a report of two cases and review of the literature.
001315 (2018) Hiroki Wakabayashi [Japon] ; Takahiko Hamaguchi [Japon] ; Nobuto Nagao [Japon] ; Sho Kato [Japon] ; Takahiro Iino [Japon] ; Tomoki Nakamura [Japon] ; Akihiro Sudo [Japon]Interleukin-6 receptor inhibitor suppresses bone metastases in a breast cancer cell line.
002379 (2014) Hiroki Wakabayashi [Japon] ; Shinya Takigawa [Japon] ; Masahiro Hasegawa [Japon] ; Takuya Kakimoto [Japon] ; Kakunoshin Yoshida [Japon] ; Akihiro Sudo [Japon]Polyarticular late infection of total joint arthroplasties in a patient with rheumatoid arthritis treated with anti-interleukin-6 therapy.
002D76 (2013) Hiroki Wakabayashi [Japon] ; Masahiro Hasegawa [Japon] ; Kakunoshin Yoshida [Japon] ; Kusuki Nishioka [Japon] ; Akihiro Sudo [Japon]Hip score and disease activity correlation in patients with rheumatoid arthritis after total hip arthroplasty
003433 (2012) Hiroki Wakabayashi [Japon] ; Masahiro Hasegawa ; Yosuke Nishioka ; Akihiro Sudo ; Kusuki NishiokaWhich subgroup of rheumatoid arthritis patients benefits from switching to tocilizumab versus etanercept after previous infliximab failure? A retrospective study.
003733 (2012) Hiroki Wakabayashi [Japon] ; Masahiro Hasegawa [Japon] ; Yosuke Nishioka [Japon] ; Yukari Minami [Japon] ; Kusuki Nishioka [Japon] ; Akihiro Sudo [Japon]Clinical outcome in patients with rheumatoid arthritis switched to tocilizumab after etanercept or infliximab failure
003A98 (2011) Hiroki Wakabayashi [Japon] ; Akihiro Sudo [Japon] ; Yosuke Nishioka [Japon] ; Masahiro Hasegawa [Japon] ; Yukari Minami [Japon] ; Kusuki Nishioka [Japon]Repeat etanercept administration restores clinical response of patients with rheumatoid arthritis

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Merge

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/Author.i -k "Akihiro Sudo" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/Author.i  \
                -Sk "Akihiro Sudo" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Merge
   |type=    indexItem
   |index=    Author.i
   |clé=    Akihiro Sudo
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021